FOLH1 and posterior cortical atrophy: The first study to analyze the possible role of [68Ga]Ga-PSMA-11 PET/MRI in the clinical setting of risk classification of PCa subjects and AS was published by Grubmüller et al. [20], who included 122 PCa patients and evaluated the staging performances of this imaging modality and its impact on therapeutic decisions.